Heat shock protein 27 is involved in SUMO-2/3 modification of heat shock factor 1 and thereby modulates the transcription factor activity

Oncogene

Volumn 28, Issue 37, 2009, Pages 3332-3344

  Brunet Simioni, M ^a,b   De Thonel, A ^a,b   Hammann, A ^a,b   Joly, A L ^a,b   Bossis, G ^c,d   Fourmaux, E ^a   Bouchot, A ^a   Landry, J ^e   Piechaczyk, M ^c,d   Garrido, C ^a,b,f  

^a Chu   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c CNRS   (France)

^d UNIV MONTPELLIER   (France)

^e UNIVERSITÉ LAVAL   (Canada)

^f DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 27; HEAT SHOCK TRANSCRIPTION FACTOR 1; LYSINE; OLIGOMER; SUMO 2 PROTEIN; SUMO 3 PROTEIN; SUMO PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; CONJUGATION; CONTROLLED STUDY; GEL FILTRATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUMOYLATION; TRANSCRIPTION REGULATION; UBIQUITINATION;

ANIMALS; CELL NUCLEUS; DNA-BINDING PROTEINS; HELA CELLS; HSP27 HEAT-SHOCK PROTEINS; HUMANS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN TRANSPORT; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUBSTRATE SPECIFICITY; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; UBIQUITINS;

EID: 70349287559     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.188     Document Type: Article

References (43)

1. Anckar J, Hietakangas V, Denessiouk K, Thiele DJ, Johnson MS, Sistonen L. (2006). Inhibition of DNA binding by differential sumoylation of heat shock factors. Mol Cell Biol 26: 955-964.
2. Anckar J, Sistonen L. (2007a). Heat shock factor 1 as a coordinator of stress and developmental pathways. Adv Exp Med Biol 594: 78-88.
3. Anckar J, Sistonen L. (2007b). SUMO: getting it on. Biochem Soc Trans 35: 1409-1413
4. Ayaydin F, Dasso M. (2004). Distinct in vivo dynamics of vertebrate SUMO paralogues. Mol Biol Cell 15: 5208-5218.
5. Blomster HA, Hietakangas V, Wu J, Kouvonen P, Hautaniemi S, Sistonen L. (2009). Novel proteomics strategy brings insight into the prevalence of SUMO-2 target sites. Mol Cell Proteomics 8: 1382-1390.
6. Bossis G, Malnou CE, Farras R, Andermarcher E, Hipskind R, Rodriguez M et al. (2005). Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol Cell Biol 25: 6964-6979.
7. Bossis G, Melchior F. (2006). Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes. Mol Cell 21: 349-357.
8. Bruey JM, Paul C, Fromentin A, Hilpert S, Arrigo AP, Solary E et al. (2000). Differential regulation of HSP27 oligomerization in tumor cells grown in vitro and in vivo. Oncogene 19: 4855-4863.
9. Caignard A, Genne P, Olsson NO, Oriol R, Martin F. (1990). F11C antigen: A membrane marker able to distinguish two regressive and progressive variants from a rat colon adenocarcinoma. Int J Cancer 46: 633-639.
10. Charette SJ, Lavoie JN, Lambert H, Landry J. (2000). Inhibition of Daxx-mediated apoptosis by heat shock protein 27. Mol Cell Biol 20: 7602-7612.
11. Didelot C, Lanneau D, Brunet M, Joly AL, De Thonel A, Chiosis G et al. (2007). Anti-cancer therapeutic approaches based on intracellular and extracellular heat shock proteins. Curr Med Chem 14: 2839-2847. (Pubitemid 350201651)
12. Didelot C, Schmitt E, Brunet M, Maingret L, Parcellier A, Garrido C. (2006). Heat shock proteins: endogenous modulators of apoptotic cell death. Handb Exp Pharmacol 172: 171-198.
13. During RL, Gibson BG, Li W, Bishai EA, Sidhu GS, Landry J et al. (2007). Anthrax lethal toxin paralyzes actin-based motility by blocking Hsp27 phosphorylation. EMBO J 26: 2240-2250.
14. Garrido C, Brunet M, Didelot C, Zermati Y, Schmitt E, Kroemer G. (2006). Heat shock proteins 27 and 70: Anti-apoptotic proteins with tumorigenic properties. Cell Cycle 5: 2592-2601.
15. Garrido C, Fromentin A, Bonnotte B, Favre N, Moutet M, Arrigo AP et al. (1998). Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones. Cancer Res 58: 5495-5499.
16. Geiss-Friedlander R, Melchior F. (2007). Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 8: 947-956.
17. Gill G. (2003). Post-translational modification by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity. Curr Opin Genet Dev 13: 108-113.
18. Guo D, Han J, Adam BL, Colburn NH, Wang MH, Dong Z et al. (2005). Proteomic analysis of SUMO4 substrates in HEK293 cells under serum starvation-induced stress. Biochem Biophys Res Commun 337: 1308-1318.
19. Gurbuxani S, Bruey JM, Fromentin A, Larmonier N, Parcellier A, Jaattela M et al. (2001). Selective depletion of inducible HSP70 enhances immunogenicity of rat colon cancer cells. Oncogene 20: 7478-7485.
20. Hay RT. (2005). SUMO: a history of modification. Mol Cell 18: 1-12.
21. Hietakangas V, Ahlskog JK, Jakobsson AM, Hellesuo M, Sahlberg NM, Holmberg CI et al. (2003). Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1. Mol Cell Biol 23: 2953-2968.
22. Hietakangas V, Anckar J, Blomster HA, Fujimoto M, Palvimo JJ, Nakai A et al. (2006). PDSM, a motif for phosphorylation-dependent SUMO modification. Proc Natl Acad Sci USA 103: 45-50.
23. Holmberg CI, Hietakangas V, Mikhailov A, Rantanen JO, Kallio M, Meinander A et al. (2001). Phosphorylation of serine 230 promotes inducible transcriptional activity of heat shock factor 1. EMBO J 20: 3800-3810.
24. Holmberg CI, Tran SE, Eriksson JE, Sistonen L. (2002). Multisite phosphorylation provides sophisticated regulation of transcription factors. Trends Biochem Sci 27: 619-627.
25. Hong Y, Rogers R, Matunis MJ, Mayhew CN, Goodson ML, Park-Sarge OK et al. (2001). Regulation of heat shock transcription factor 1 by stress-induced SUMO-1 modification. J Biol Chem 276: 40263-40267.
26. Jaattela M. (1995). Over-expression of hsp70 confers tumorigenicity to mouse fibrosarcoma cells. Int J Cancer 60: 689-693.
27. Joanisse DR, Inaguma Y, Tanguay RM. (1998). Cloning and developmental expression of a nuclear ubiquitin-conjugating enzyme (DmUbc9) that interacts with small heat shock proteins in Drosophila melanogaster. Biochem Biophys Res Commun 244: 102-109.
28. Johnson ES. (2004). Protein modification by SUMO. Annu Rev Biochem 73: 355-382.
29. Lambert H, Charette SJ, Bernier AF, Guimond A, Landry J. (1999). HSP27 multimerization mediated by phosphorylation-sensitive intermolecular interactions at the amino terminus. J Biol Chem 274: 9378-9385.
30. Lee YJ, Kim EH, Lee JS, Jeoung D, Bae S, Kwon SH et al. (2008). HSF1as a mitotic regulator: Phosphorylation of HSF1 by Plk1 is essential for mitotic progression. Cancer Res 68: 7550-7560.
31. McMillan DR, Xiao X, Shao L, Graves K, Benjamin IJ. (1998). Targeted disruption of heat shock transcription factor 1 abolishes thermotolerance and protection against heat-inducible apoptosis. J Biol Chem 273: 7523-7528.
32. Mehlen P, Kretz-Remy C, Briolay J, Fostan P, Mirault ME, Arrigo AP. (1995a). Intracellular reactive oxygen species as apparent modulators of heat-shock protein 27 (hsp27) structural organization and phosphorylation in basal and tumour necrosis factor alpha-treated T47D human carcinoma cells. Biochem J 312(Pt 2): 367-375.
33. Mehlen P, Mehlen A, Guillet D, Preville X, Arrigo AP. (1995b). Tumor necrosis factor-alpha induces changes in the phosphoryla-tion, cellular localization, and oligomerization of human hsp27, a stress protein that confers cellular resistance to this cytokine. J Cell Biochem 58: 248-259.
34. Parcellier A, Brunet M, Schmitt E, Col E, Didelot C, Hammann A et al. (2006). HSP27 favors ubiquitination and proteasomal degradation of p27Kip1 and helps S-phase re-entry in stressed cells. FASEB J 20: 1179-1181.
35. Pirkkala L, Nykanen P, Sistonen L. (2001). Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J 15: 1118-1131.
36. Rogalla T, Ehrnsperger M, Preville X, Kotlyarov A, Lutsch G, Ducasse C et al. (1999). Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/ tumor necrosis factor alpha by phosphorylation. J Biol Chem 274: 18947-18956.
37. Saitoh H, Hinchey J. (2000). Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J Biol Chem 275: 6252-6258.
38. Schmitt E, Gehrmann M, Brunet M, Multhoff G, Garrido C. (2007). Intracellular and extracellular functions of heat shock proteins: Repercussions in cancer therapy. J Leukoc Biol 81: 15-27. (Pubitemid 46021247)
39. Shi Y, Mosser DD, Morimoto RI. (1998). Molecular chaperones as HSF1-specific transcriptional repressors. Genes Dev 12: 654-666.
40. Voellmy R, Boellmann F. (2007). Chaperone regulation of the heat shock protein response. Adv Exp Med Biol 594: 89-99.
41. Westerheide SD, Kawahara TL, Orton K, Morimoto RI. (2006). Triptolide, an inhibitor of the human heat shock response that enhances stress-induced cell death. J Biol Chem 281: 9616-9622.
42. Xiao X, Zuo X, Davis AA, McMillan DR, Curry BB, Richardson JA et al. (1999). HSF1 is required for extra-embryonic development, postnatal growth and protection during inflammatory responses in mice. EMBO J 18: 5943-5952.
43. Zhu J, Zhu S, Guzzo CM, Ellis NA, Sung KS, Choi CY et al. (2008). Small ubiquitin related modifier (SUMO) binding determines substrate recognition and paralog-selective SUMO modification. J Biol Chem 283: 29405-29415.